Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy.
about
The viral etiology of AIDS-associated malignanciesFactors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio De Janeiro, BrazilHuman papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers.Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful.Prevalence of human papillomavirus infection of the anal canal in women: A prospective analysis of high-risk populationsInfluence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation.Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia.Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda.Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe.Structural and sociocultural factors associated with cervical cancer screening among HIV-infected African American women in Alabama.Review of HIV-Related Cytopathology.The impact of HAART on HPV-related cervical disease.International scientific collaboration in HIV and HPV: a network analysis.Exploring barriers to the delivery of cervical cancer screening and early treatment services in Malawi: some views from service providersA cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling studyPrevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings.Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.Integrating cervical cancer prevention initiatives with HIV care in resource-constrained settings: A formative study in Durban, South Africa.The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.High-risk human papillomavirus infection in HIV-positive African women living in Europe.Stress Management, Depression and Immune Status in Lower Income Racial/Ethnic Minority Women Co-infected with HIV and HPV.The impact of human immunodeficiency virus infection on cervical preinvasive and invasive neoplasia in South Africa.HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mumbai, India: 12-month follow-upSubstantial increase in the frequency of circulating CD4+NKG2D+ T cells in patients with cervical intraepithelial neoplasia grade 1.Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.The burden of HPV-associated anogenital cancers.Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country.Genotypic characterisation of human papillomavirus infections among persons living with HIV infection; a case-control study in Kumasi, Ghana.Impact of Highly Active Antiretroviral Therapy on the Natural History of Cervical Precancerous Lesions: A 17-Year Institutional Longitudinal Cohort Study.Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.Desempenho do exame citológico e da captura híbrida II no rastreamento de lesões intraepiteliais escamosas de alto grau em mulheres HIV+
P2860
Q24685892-49C9C0DA-FD71-404C-A207-37FC1ECF2B39Q28387339-E48E09AC-CAB6-49A2-A911-C12B6771A5C0Q33491795-E244A09C-D174-4F4E-B9BB-89B0500EA4E0Q33526682-D3C6D91B-1A5D-4122-AF07-5F08C44DD7CEQ33574329-90F2DEB7-5CCC-44A9-93B1-2ADF8715AE0DQ33599099-682ECC83-50A1-4784-BEF5-93AEAFCA6F07Q33638545-3F24D466-DE8E-4AC5-943D-BDF1EF9695F8Q33762765-BCA2F5E8-EAEE-4EF5-B6C7-2DD221F1FD05Q33869309-3B31A680-E53D-4676-8F87-30CFA3207BD4Q33988391-F920E054-E9F7-4519-9823-0D2348F077DCQ34073196-C1D3C79B-60F8-478A-89D4-9B9C6B5235BBQ34354553-13CF1228-010B-45AB-A0B3-C04843818BF9Q34576482-802816F7-564E-46EE-AC3D-88A0A3D813A7Q34743282-6C653689-CAA1-4FBE-B8F1-AE4DC2E726A6Q34802726-7CDB2A8D-2826-4B92-A27B-82CF4C2D54C9Q34954078-6E249436-9A50-44AA-8BF2-67E627E5EE35Q35025062-E815E3A3-DA12-43F9-9C92-F57E8270D5C9Q35135108-12CF9AAD-F431-4E3A-B4E5-208E5FBE3979Q35223408-1F86839E-E0F2-400B-9E0A-A386E9F4CEBAQ35671337-4731D64C-5C11-47D9-937A-15970B7DF7D0Q35709526-E06FAA57-31F5-43F0-B40A-52F1EB9A70C7Q35884800-74F257A4-330A-4FD9-BB20-2D157937C4B2Q35917465-E4F2B74C-4632-4766-BC7F-39FB471D308BQ35921084-D65BD7F2-4123-48C5-9068-5E34838F5006Q36563576-8CE0593C-C340-4E4E-B330-0A5ABA6AE23FQ36614735-6B0C1337-8329-40E2-8FE7-51B2D38CCA37Q36697193-1B1ACF78-77B4-419E-B35E-BC01789F93E3Q37027124-81F1FA6D-F266-46B6-A71F-EF38C8D99AAEQ37103648-921D421D-86AC-49B8-8DCE-182791DB0850Q37116995-BB84E4E5-1840-4936-8F39-14FC985ADF68Q37347357-272EAC55-E8CB-49AF-A3B4-4AB86360AB5EQ38239507-88B3BD5D-FA64-44CD-9B27-EC2D675C7AD0Q38646429-F59E6CC9-9906-4E51-BA6C-C4C89D5057CEQ39144897-E1C473AA-9258-4694-B3A4-955A018EC224Q39553755-73240665-4AC4-4D6E-BABE-1FF52018872BQ39614507-9B24F199-5074-4C0D-A0A6-EE5700F7FE89Q42236899-EE509CB4-0481-4D3E-AC3B-ACB257FDD048Q45477958-F072FA90-C9A3-4905-AD70-7B966B3835C7Q57163487-F86A4D95-179C-4FFB-8270-0C684CAF0822
P2860
Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cervical human papillomavirus ...... active antiretroviral therapy.
@ast
Cervical human papillomavirus ...... active antiretroviral therapy.
@en
type
label
Cervical human papillomavirus ...... active antiretroviral therapy.
@ast
Cervical human papillomavirus ...... active antiretroviral therapy.
@en
prefLabel
Cervical human papillomavirus ...... active antiretroviral therapy.
@ast
Cervical human papillomavirus ...... active antiretroviral therapy.
@en
P1476
Cervical human papillomavirus ...... active antiretroviral therapy.
@en
P2093
Joel M Palefsky
P304
P356
10.1097/00001622-200309000-00007
P577
2003-09-01T00:00:00Z